Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/04/2017 → 31/05/2020 |
Funding
- Asthma and Lung UK: £199,855.00
Immunotherapy for mesothelioma using ErbB re-targeted CAR T-cells in combination with PD-1 checkpoint inhibition
- Maher, John (Primary Investigator)
- Davies, David (Co-Investigator)
- Spicer, James (Co-Investigator)
Project: Research